Clinical Trial Update: Monitoring of Anti-TFPI in Hemophilia

View source ↗

Summary

A clinical trial is monitoring an anti-TFPI therapy for hemophilia, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Anti-TFPI therapy (anti-TFPI monoclonal antibody)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hemophilia, Rebalancing Agents | Status: RECRUITING